// App-Quantinova.ai

e11527 : Neutrophil-guided dosing of anthracycline/cyclophosphamide chemotherapy in breast cancer: A feasibility study.

Researchers

Presenter

  • Johanna Maria van Pelt-Sprangers

Principal Investigators

  • Corry Leunis

  • Felix De Jongh

Medical Centers

  • Ikazia Hospital, Rotterdam, Netherlands

  • Ikazia Hospital, Rotterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Neutropenia

  • Solid malignancies

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NL32077

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved